Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,673,406
+$152,716 QoQ
Shares Held
6,650
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#2,104
of 4,153 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Johnson Financial Group, LLC holds $7,394,397 across 9 Drug Manufacturers - General names. ABBV ranks #1 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
6,650 | $1,673,406 | |
| 2 | LLY |
ELI LILLY & Co
|
1,147 | $1,375,746 | |
| 3 | JNJ |
Johnson & Johnson
|
4,823 | $1,224,897 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,613 | $1,106,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,967 | $880,210 | |
| 6 | AMGN |
Amgen Inc
|
1,188 | $430,198 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,210 | $242,580 | |
| 8 | SNY |
Sanofi
|
5,501 | $234,672 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,673,406 | 6,650 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,520,690 | 6,992 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,001,471 | 4,383 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $527,679 | 2,279 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $423,027 | 2,279 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $513,114 | 2,449 | Shares | Sole | 2025-05-12 | |
| 2022-03-31 | $203,123 | 1,253 | Shares | Sole | 2022-05-06 | |
| No filing history on record for this holder in this stock. | ||||||